• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron

tetano

Editor, Senior Moderator
Nat Commun


. 2025 Jul 29;16(1):6951.
doi: 10.1038/s41467-025-62300-0. A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron

Xiaoyuan Lin[SUP] #[/SUP][SUP] 1 2 [/SUP], Zhou Sha[SUP] #[/SUP][SUP] 3 [/SUP], Chunlin Zhang[SUP] #[/SUP][SUP] 3 [/SUP], Julia M Adler[SUP] 2 [/SUP], Ricardo Martin Vidal[SUP] 2 [/SUP], Christine Langner[SUP] 2 [/SUP], Beibei Fu[SUP] 1 3 [/SUP], Yan Xiong[SUP] 3 [/SUP], Meng Tan[SUP] 3 [/SUP], Chen Jiang[SUP] 3 [/SUP], Hao Zeng[SUP] 4 [/SUP], Xiaokai Zhang[SUP] 4 [/SUP], Qian Li[SUP] 1 [/SUP], Jingmin Yan[SUP] 1 [/SUP], Xiaoxue Lu[SUP] 1 [/SUP], Shiwei Wang[SUP] 1 [/SUP], Xuhu Mao[SUP] 1 [/SUP], Dusan Kunec[SUP] 2 [/SUP], Jakob Trimpert[SUP] 5 6 [/SUP], Haibo Wu[SUP] 7 [/SUP], Quanming Zou[SUP] 8 [/SUP], Zhenglin Zhu[SUP] 9 [/SUP]



Affiliations
Abstract

How SARS-CoV-2 Omicron evolved remains obscure. T492I, an Omicron-specific mutation encountered in SARS-CoV-2 nonstructural protein 4 (NSP4), enhances viral replication and alters nonstructural protein cleavage, inferring potentials to drive evolution. Through evolve-and-resequence experiments of SARS-CoV-2 wild-type (hCoV-19/USA/WA-CDC-02982585-001/2020, A) and Delta strains (B.1.617) with or without T492I, this study demonstrates that the NSP4 mutation T492I confers accelerated phenotypic adaption and a predisposition to the emergence of SARS-CoV-2 Omicron-like variants. The T492I-driven evolution results in accelerated enhancement in viral replication, infectivity, immune evasion capacity, receptor-binding affinity and potential for cross-species transmission. Aside from elevated mutation rates and impact on deaminases, positive epistasis between T492I and adaptive mutations could potentially mechanistically facilitate the shifts in mutation spectra and indirectly determines the Omicron-predisposing evolution. These suggest a potentially important role of the driver mutation T492I in the evolution of SARS-CoV-2 Omicron variants. Our findings highlight the existence and importance of mutation-driven predisposition in viral evolution.


 
Back
Top